Delivery Order SPE2DB22D1202-SPE2DB25FVJC1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under a competitive procurement process. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,958.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was awarded without set-aside designations through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a $3,128.12 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,868.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 7, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,342.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a $3,648.80 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price contract, which is part of a larger Indefinite Delivery Contract vehicle, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,300.52 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal medical procurement requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVJC1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,388.14 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitive, non-set-aside contract operates under a firm fixed price arrangement and represents a delivery order against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. AmerisourceBergen's role as a critical federal medical vendor demonstrates its capability to meet Defense Department procurement requirements across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/22/25 |